1. Home
  2. PLAG vs GNPX Comparison

PLAG vs GNPX Comparison

Compare PLAG & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLAG
  • GNPX
  • Stock Information
  • Founded
  • PLAG 1986
  • GNPX 2009
  • Country
  • PLAG United States
  • GNPX United States
  • Employees
  • PLAG N/A
  • GNPX N/A
  • Industry
  • PLAG Packaged Foods
  • GNPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLAG Consumer Staples
  • GNPX Health Care
  • Exchange
  • PLAG Nasdaq
  • GNPX Nasdaq
  • Market Cap
  • PLAG 12.8M
  • GNPX 10.8M
  • IPO Year
  • PLAG N/A
  • GNPX 2018
  • Fundamental
  • Price
  • PLAG $2.25
  • GNPX $9.74
  • Analyst Decision
  • PLAG
  • GNPX
  • Analyst Count
  • PLAG 0
  • GNPX 0
  • Target Price
  • PLAG N/A
  • GNPX N/A
  • AVG Volume (30 Days)
  • PLAG 140.9K
  • GNPX 57.6M
  • Earning Date
  • PLAG 11-14-2025
  • GNPX 11-12-2025
  • Dividend Yield
  • PLAG N/A
  • GNPX N/A
  • EPS Growth
  • PLAG N/A
  • GNPX N/A
  • EPS
  • PLAG N/A
  • GNPX N/A
  • Revenue
  • PLAG $6,069,007.00
  • GNPX N/A
  • Revenue This Year
  • PLAG N/A
  • GNPX N/A
  • Revenue Next Year
  • PLAG N/A
  • GNPX N/A
  • P/E Ratio
  • PLAG N/A
  • GNPX N/A
  • Revenue Growth
  • PLAG N/A
  • GNPX N/A
  • 52 Week Low
  • PLAG $0.47
  • GNPX $0.14
  • 52 Week High
  • PLAG $5.52
  • GNPX $12.97
  • Technical
  • Relative Strength Index (RSI)
  • PLAG 56.48
  • GNPX 82.32
  • Support Level
  • PLAG $2.02
  • GNPX $0.27
  • Resistance Level
  • PLAG $2.83
  • GNPX $12.97
  • Average True Range (ATR)
  • PLAG 0.29
  • GNPX 0.41
  • MACD
  • PLAG 0.03
  • GNPX 0.96
  • Stochastic Oscillator
  • PLAG 47.27
  • GNPX 70.46

About PLAG Planet Green Holdings Corp.

Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Share on Social Networks: